New England chain restaurant to open new Mass. location this year
A popular New England chain restaurant is slated to open its newest location later this year.
Tavern in the Square is planning to open its new Braintree restaurant by late summer/early fall, a spokesperson for the company told MassLive.
The restaurant will take over the former space of TGI Friday's at 60 Forbes Road in Braintree.
Braintree Tavern in the Square will have a large bar and indoor dining room in addition to a spacious covered patio.
'We're excited to bring the Tavern in the Square experience to the South Shore and look forward to becoming part of the Braintree community,' the spokesperson said.
The opening would mark Tavern in the Square's 14th Massachusetts spot and its 18th overall — joining other locations in New Hampshire, Connecticut and Rhode Island.
The chain restaurant is also eyeing a new location in Bedford, New Hampshire, according to its website.
Tavern in the Square is turning 20 in 2025. The chain restaurant is known for its scratch-made American cuisine, including an extensive selection of gluten-free and allergy-friendly options.
Spice of life: This restaurant brings Sri Lankan street food to the Pioneer Valley
New Raising Cane's with double drive-thru to open in MetroWest next week
Snack, sip and sing at Boston's new underground piano bar
Read the original article on MassLive.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
17 minutes ago
- Yahoo
Meta Sues Hong Kong Firm in Crackdown on Deepfake Nude Apps
(Bloomberg) -- Meta Platforms Inc. is suing a Hong Kong-based business for allegedly promoting so-called nudify apps, as the Facebook owner attempts to combat a surge in naked and sexual images created by artificial intelligence. Shuttered NY College Has Alumni Fighting Over Its Future Trump's Military Parade Has Washington Bracing for Tanks and Weaponry NYC Renters Brace for Price Hikes After Broker-Fee Ban NY Long Island Rail Service Resumes After Grand Central Fire Do World's Fairs Still Matter? The tech giant said it filed a lawsuit in Hong Kong to stop Joy Timeline HK Ltd. allegedly advertising CrushAI apps on Meta platforms. The apps allow people to create AI-generated nude or sexually explicit images of individuals without their consent, Meta said in a post on its website Thursday. The legal action is part of broader crackdown on online non-consensual sexual images, which can be used for sextortion, blackmail and abuse. Meta, which also owns Instagram, said it will now share with other technology companies information about ads, accounts and content that have been removed for promoting nudify apps. In its post, Meta said it had noticed 'concerning growth' in this area. 'With nudify apps being advertised across the internet — and available in App Stores themselves — removing them from one platform alone isn't enough,' Meta said. Joy Timeline didn't immediately respond to a request for comment sent to its public email address. Meta is under fire around the world for not doing enough to protect teenagers and young people. In Australia, a world-first ban on social media for under-16s will start this year, and other countries are tightening content oversight. But while Meta is fighting back against some fake, auto-generated material, it's pushing deeper into artificial intelligence more broadly. Advertisers promoting nudify apps are changing tactics to avoid being caught, according to Meta. Some use benign images to evade detection, while others swiftly create new domain names to replace blocked websites. In response, Meta said it has developed technology to identify such ads, even when they don't include nudity. In its Hong Kong lawsuit, Meta claims Joy Timeline repeatedly tried to circumvent ad review processes after they were removed for breaking Meta's rules. --With assistance from Kurt Wagner and Newley Purnell. New Grads Join Worst Entry-Level Job Market in Years American Mid: Hampton Inn's Good-Enough Formula for World Domination The Spying Scandal Rocking the World of HR Software The SEC Pinned Its Hack on a Few Hapless Day Traders. The Full Story Is Far More Troubling Cavs Owner Dan Gilbert Wants to Donate His Billions—and Walk Again ©2025 Bloomberg L.P. Sign in to access your portfolio
Yahoo
18 minutes ago
- Yahoo
Oil prices ease but hover near two-month highs as Middle East tensions escalate
Oil prices fell on Thursday morning, easing back after rallying but hovered around their highest point in two months, as investors eyed escalating tensions in the Middle East and a potential disruption to supply. Brent crude futures (BZ=F) fell 0.9% to $68.31 a barrel, at the time of writing, while West Texas Intermediate futures (CL=F) declined 0.9% at $67.56 a barrel. US president Donald Trump said on Wednesday that some of US personnel were being moved out of the Middle East because "it could be a dangerous place to be". This came following reports earlier in the day that the US was preparing a partial evacuation of its embassy in Baghdad, Iraq. CBS News reported that US officials had been told Israel was ready to launch an operation into Iran and that the US anticipated Iran could retaliate on certain American sites in Iraq. Read more: FTSE 100 LIVE: Stocks slump as UK GDP contracts in blow to Rachel Reeves Trump said in an interview with the New York Post, released earlier on Wednesday, that he was "less confident" about getting Iran to agree to halt its nuclear programme. In a press briefing on Wednesday, Iran's defence minister Aziz Nasirzadeh said: "Some officials on the other side threaten conflict if negotiations don't come to fruition. If a conflict is imposed on us ... all US bases are within our reach and we will boldly target them in host countries." Matt Britzman, senior equity analyst at Hargreaves Lansdown, said that oil prices remain near a two-month high "driven by rising US-Iran tensions and fears of supply disruptions. At the same time, optimism about energy demand grew after the US and China reached a trade framework, and US crude stockpiles fell more than expected, signalling strong consumption." Gold prices jumped on Thursday morning, as Middle East tensions buoyed demand for the safe-haven asset. Gold futures (GC=F) surged nearly 1% to $3,376 per ounce at the time of writing, while the spot gold price advanced 0.1% to $3,359.49 per ounce. The precious metal is considered to be a safe haven asset, in acting as a hedge amid political and economic uncertainty. Britzman said: "Gold was another winner, with its safe-haven appeal gaining traction amid rising Middle East tensions and softer US inflation data, which gave a modest boost to expectations for rate cuts." Read more: UK economy shrinks by 0.3% in April Data released on Wednesday showed that the US consumer prices index (CPI) rose by 0.1% month-on-month, which was below April's 0.2% rise and lower than economists' estimates of a 0.2% monthly gain in prices. On an annual basis, CPI rose 2.4% in May, a slight uptick from April's 2.3% gain, which marked the lowest yearly increase since February 2021. Investors were also monitoring the latest trade developments, after Trump said in a social media post on Wednesday afternoon that Washington's deal with China is "DONE, SUBJECT TO FINAL APPROVAL WITH PRESIDENT XI AND ME". The pound rose slightly against the dollar (GBPUSD=X) on Thursday morning, up 0.2% to $1,3571, despite a bigger than expected contraction in UK economic growth. The Office for National Statistics (ONS) said that the UK's gross domestic product (GDP) — the standard measure of an economy's value — shrank by 0.3% in April, which was more than the 0.1% contraction expected by economists. The fall followed growth of 0.2% in March and a 0.7% rise in GDP in the first quarter. This latest economic data comes a day after chancellor Rachel Reeves delivered the UK spending review, sharing details of governmental department budgets for the next few years. Key announcements included a £29bn per year increase in funding for the NHS, while the government's defence budget is set to increase from 2.3% to 2.6% of the country's gross domestic product (GDP) from 2027. Reeves also shared details of a £39bn boost to funding for affordable housing and £15.6bn for transport projects in England's largest city regions outside of London. Stocks: Create your watchlist and portfolio Danni Hewson, head of financial analysis at AJ Bell, said: "It's hard not to look at today's headline fall in economic growth as anything other than inevitable. Company after company had warned the chancellor that the decisions taken during last year's budget would impact business growth and create huge uncertainty about existing staffing levels." "Rachel Reeves has said she is determined to deliver growth, and her spending plans have been given a cautious welcome by business groups up and down the country — but the caution speaks volumes," she said. "Can the government's trade policies and spending plans deliver the promised growth or was the energy demonstrated by the UK economy at the start of the year merely a tease?" In other currency moves, the pound fell 0.4% against the euro (GBPEUR=X), trading at €1.1743 at the time of writing. More broadly, the the FTSE 100 (^FTSE) was little changed, trading at 8,863 points at the time writing. For more details, on broader market movements check our live coverage here. Read more: Bitcoin price dips as markets cool after US-China tariff talks What you need to know about UK's private stock market Pisces UK house prices remain flat as buyer demand and sales steady
Associated Press
21 minutes ago
- Associated Press
Catheter Precision (VTAK) Reports Key Progress for the LockeT Product
FORT MILL, S.C., June 12, 2025 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (VTAK - NYSE/American), a US based medical device company focused on developing technologically advanced products for the cardiac electrophysiology market announced that LockeT sales for Q2 2025 are on track to be the highest to date. Second quarter 2025 LockeT sales are already outpacing Q2 2024 sales with a 200% increase. Catheter Precision now has several US hospitals that are on track to issue more than $100,000 in purchase orders each for LockeT by the end of 2025. These hospitals include Montefiore (Bronx, NY), Eisenhower Health (Rancho Mirage, CA), and Overland Park Regional Medical Center (Overland Park, KS). As previously announced, LockeT received the CE Mark enabling sales in Europe. Catheter Precision has secured a new distributor in Italy and anticipates additional distributors in the coming days for Spain, Portugal and the UK and is actively searching for the right partner is other EU countries. David Jenkins, CEO of Catheter Precision said, 'We are excited about the upcoming activities, sales pipeline and expanded use by existing customer to increase revenue generated by LockeT. At this time, there is a live case scheduled on Monday, Juen 16 with a key opinion leader where he will demonstrate LockeT during an Italian symposium, increasing its awareness to the new market. As a company, we continue to focus on improving product awareness, increasing product usage and expanding our footprint into Europe.' About LockeT Catheter Precision's LockeT is a suture retention device intended to assist in wound closure after percutaneous venous punctures. LockeT is a Class 1 device registered with the FDA and has received CE Mark approval. About Catheter Precision Catheter Precision is an innovative U.S.-based medical device company bringing new solutions to market to improve the treatment of cardiac arrhythmias. It is focused on developing groundbreaking technology for electrophysiology procedures by collaborating with physicians and continuously advancing its products. Cautionary Note Regarding Forward-Looking Statements Statements in this press release may contain 'forward-looking statements' within the meaning of the Private Securities Litigation Reform Act of 1995 that are subject to substantial risk and uncertainties. Forward-looking statements can be identified by words such as 'believe,' 'anticipate,' 'may,' 'might,' 'can,' 'could,' 'continue,' 'depends,' 'expect,' 'expand,' 'forecast,' 'intend,' 'predict,' 'plan,' 'rely,' 'should,' 'will,' 'may,' 'seek,' or the negative of these terms and other similar expressions, although not all forward-looking statements contain these words. These forward-looking statements include, but are not limited to, statements regarding product evaluations at the hospital, and that the purchase order indicates that the hospital and its staff see the value and benefits that LockeT can bring and expectations regarding LockeT evaluations in the coming weeks. The Company's expectations and beliefs regarding these matters may not materialize. Actual outcomes and results may differ materially from those contemplated by these forward-looking statements as a result of uncertainties, risks and changes in circumstances, including but not limited to risks and uncertainties included under the caption 'Risk Factors' in the Company's Form 10-K filed with the SEC and available at The forward-looking statements included in this communication are made only as of the date hereof. The Company assumes no obligation and does not intend to update these forward-looking statements, except as required by law. CONTACTS: At the Company David Jenkins 973-691-2000 [email protected] # # #
